ALK-2 inhibitors (Oncodesign Biotechnology)

N/A

Report date: 2025/01/26 18:16:06
NME

Base Information

Drug NameALK-2 inhibitors (Oncodesign Biotechnology)
Drug Alias NameOD-66
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActivin receptor type-1 inhibitors
TargetsActivin receptor type-1
Therapy Area/IndicationsAnemiaMyositis OssificansNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncodesign Services
China Registration ClassN/A

Develop Information

Active CompaniesOncodesign Services
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsMyositis OssificansNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A